<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940406-2-00072</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=84 g=1 f=1 --> Other Requirements  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Paperwork Reduction Act  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Projects that involve the collection of information from ten or more individuals and funded by this cooperative agreement will be subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Human Subjects  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> If the proposed project involves research on human subjects, the applicant must comply with the Department of Health and Human Services Regulations (45 CFR part 46) regarding the protection of human subjects. Assurance must be provided to demonstrate that the project will be subject to initial and continuing review by an appropriate institutional review committee. The applicant will be responsible for providing assurance in accordance with the appropriate guidelines and form provided in the application kit.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Application Submission and Deadline  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Preapplication Letter of Intent  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Although not a prerequisite of application, a non-binding letter of intent-to-apply is requested from potential applicants. The letter should be submitted to the Grants Management Officer (whose address is reflected in section B, ``Applications''). It should be postmarked no later than one month prior to the planned submission deadline, (e.g., May 17 for June 17 submission).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The letter should identify the announcement number, indicate the intended submission deadline, name the principal investigator, and specify the study area addressed by the proposed project.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The letter of intent does not influence review of funding decisions, but it will enable CDC to plan the review more efficiently, and will ensure that each applicant receives timely and relevant information prior to application submission.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. Applications  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All applicants should use Form PHS&hyph;398 and adhere to the ERRATA Instruction Sheet for form PHS&hyph;398. The original and five copies must be submitted to Henry S. Cassell, III, Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., room 321, Atlanta, GA 30305, on or before June 17, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> C. Deadline  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. Applications shall be considered as meeting the deadline if they are either:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> A. Received on or before the deadline date, or  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Sent on or before the deadline date and received in time for submission for the review process. Applicants must request a legibly dated U.S. Postal Service Postmark or obtain a legibly dated receipt from a commercial carrier or U.S. Postal Service. Private metered postmarks shall not be acceptable as proof of timely mailing.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Late Applications: Applications which do not meet the criteria in 1.A. or 1.B. above are considered late applications. Late applications will not be considered in the current competition and will be returned to the applicant.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Where to Obtain Additional Information  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> To receive additional written information call (404) 332&hyph;4561. You will be asked to leave your name, address and phone number and will need to refer to Announcement 438. You will receive a complete program description, information on application procedures, and application forms.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> If you have questions after reviewing the contents of all documents, business management technical assistance may be obtained from Lisa Tamaroff, Grants Management Specialist, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., room 321, Mailstop E&hyph;13, Atlanta, GA 30305, telephone (404) 842&hyph;6796.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Please refer to Announcement Number 438 when requesting information and submitting an application.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Programmatic technical assistance may be obtained from Lisa Rosenblum, M.D., Lead Poisoning Prevention Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway, NE., Mailstop F&hyph;42, Atlanta, GA 30341&hyph;3724, telephone (404) 488&hyph;7330.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Potential applicants may obtain a copy of ``Healthy People 2000'' (Full Report, Stock No. 017&hyph;001&hyph;00474&hyph;0) or ``Healthy People 2000'' (Summary Report, Stock No. 017&hyph;001&hyph;00473&hyph;1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402&hyph;9325, telephone (202) 783&hyph;3238.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> To receive a copy of the Strategic Plan for the Elimination of Childhood Lead Poisoning, contact the Lead Poisoning Prevention Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway, NE., Mailstop F&hyph;42, Atlanta, GA 30341&hyph;3724, telephone (404) 488&hyph;7330.  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=3 --> Dated: March 31, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=3 --> Robert L. Foster,  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=3 --> Acting Associate Director for Management and Operations, Centers for Disease Control and Prevention (CDC).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=3 --> [FR Doc. 94&hyph;8246 Filed 4&hyph;5&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=3 --> BILLING CODE 4163&hyph;18&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            